@ARTICLE{
author={Ohe Yuichiro,...,Andric Zoran G,...,(broj koautora 17)},
year={2022},
title={Randomized phase III study comparing the efficacy and safety of CT-P16, a new biosimilar, to reference bevacizumab (Avastin (R)) in patients with metastatic or recurrent non-small cell lung cancer (NSCLC)},
journal={CANCER RESEARCH},
volume={82},
number={12},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Verschraegen Claire,Andric Zoran G,Moiseenko Fedor,Makharadze Tamta,Shevnya Sergii,Oleksiienko Alona,Ruiz Eduardo Yanez,Kim SungHyun,Ahn KeumYoung,Park TaeHong,Park Sijin,Ju Hana,Ohe Yuichiro},
year={2022},
title={Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial},
journal={BIODRUGS},
volume={36},
number={6},
pages={749-760},
document_type={Article},
}